Nagi B. Kumar

6.3k total citations
93 papers, 3.7k citations indexed

About

Nagi B. Kumar is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Nagi B. Kumar has authored 93 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 24 papers in Pathology and Forensic Medicine and 22 papers in Molecular Biology. Recurrent topics in Nagi B. Kumar's work include Cancer Risks and Factors (19 papers), Phytoestrogen effects and research (15 papers) and Tea Polyphenols and Effects (14 papers). Nagi B. Kumar is often cited by papers focused on Cancer Risks and Factors (19 papers), Phytoestrogen effects and research (15 papers) and Tea Polyphenols and Effects (14 papers). Nagi B. Kumar collaborates with scholars based in United States, Nigeria and United Kingdom. Nagi B. Kumar's co-authors include David V. Schapira, Ganna Chornokur, Kathy Allen, Gary H. Lyman, Diane Riccardi, Alan Cantor, Charles E. Cox, Julio M. Pow‐Sang, Karen Besterman‐Dahan and Barrie R. Cassileth and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Nagi B. Kumar

91 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nagi B. Kumar United States 34 1.3k 949 686 629 508 93 3.7k
Keitaro Tanaka Japan 41 1.5k 1.2× 1.1k 1.1× 688 1.0× 716 1.1× 412 0.8× 213 5.2k
François Meyer Canada 36 1.0k 0.8× 844 0.9× 902 1.3× 282 0.4× 524 1.0× 94 3.9k
Ömer Küçük United States 46 1.4k 1.1× 2.3k 2.4× 1.0k 1.5× 1.3k 2.1× 819 1.6× 206 6.8k
Isabelle Bairati Canada 36 877 0.7× 635 0.7× 686 1.0× 235 0.4× 475 0.9× 100 3.5k
Suminori Kono Japan 51 1.4k 1.1× 1.3k 1.4× 817 1.2× 1.7k 2.7× 691 1.4× 205 7.1k
Susan E. McCann United States 41 1.3k 1.0× 1.6k 1.7× 271 0.4× 1.1k 1.7× 571 1.1× 123 4.8k
Kazue Imai Japan 36 1.3k 1.0× 1.9k 2.0× 322 0.5× 1.8k 2.9× 804 1.6× 71 5.9k
Carlo Sabbà Italy 46 537 0.4× 1.5k 1.6× 1.3k 1.9× 289 0.5× 490 1.0× 211 6.7k
Katherine D. Crew United States 36 2.8k 2.2× 1.1k 1.2× 1.3k 2.0× 700 1.1× 813 1.6× 181 6.0k
Yoshitaka Tsubono Japan 44 1.5k 1.2× 560 0.6× 891 1.3× 1.3k 2.1× 471 0.9× 134 6.3k

Countries citing papers authored by Nagi B. Kumar

Since Specialization
Citations

This map shows the geographic impact of Nagi B. Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nagi B. Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nagi B. Kumar more than expected).

Fields of papers citing papers by Nagi B. Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nagi B. Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nagi B. Kumar. The network helps show where Nagi B. Kumar may publish in the future.

Co-authorship network of co-authors of Nagi B. Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Nagi B. Kumar. A scholar is included among the top collaborators of Nagi B. Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nagi B. Kumar. Nagi B. Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Nagi B., Jasreman Dhillon, Michael Poch, et al.. (2023). Challenges to Recruiting Men on Active Surveillance for Prostate Cancer in Clinical Chemoprevention Trials. Cancers. 15(4). 1257–1257.
2.
Basu, Amrita, Ganesan Ramamoorthi, Krithika N. Kodumudi, et al.. (2021). Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination. Frontiers in Immunology. 12. 786286–786286. 8 indexed citations
3.
4.
Ganguly, Aniruddha, David A. Frank, Nagi B. Kumar, Yung-Chi Cheng, & Edward Chu. (2019). Cancer Biomarkers for Integrative Oncology. Current Oncology Reports. 21(4). 32–32. 4 indexed citations
5.
Kim, Seung Joon, Ernest K. Amankwah, Hyun Y. Park, et al.. (2014). Safety and Chemopreventive Effect of Polyphenon E in Preventing Early and Metastatic Progression of Prostate Cancer in TRAMP Mice. Cancer Prevention Research. 7(4). 435–444. 23 indexed citations
6.
Kumar, Nagi B., et al.. (2011). Management of Treatment-Related Symptoms in Patients With Breast Cancer. Clinical journal of oncology nursing. 15(1). 63–71. 40 indexed citations
7.
Chornokur, Ganna, et al.. (2010). Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer. The Prostate. 71(9). 985–997. 265 indexed citations
8.
Kumar, Nagi B., Tiffany Smith, Daohai Yu, et al.. (2010). Cancer Cachexia: Traditional Therapies and Novel Molecular Mechanism-Based Approaches to Treatment. Current Treatment Options in Oncology. 11(3-4). 107–117. 79 indexed citations
9.
Odedina, Folakemi T., Titilola O Akinremi, Frank Chinegwundoh, et al.. (2009). Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa. Infectious Agents and Cancer. 4(S1). S2–S2. 183 indexed citations
10.
Cassileth, Barrie R., Gary Deng, Jorge Gómez, et al.. (2007). Complementary Therapies and Integrative Oncology in Lung Cancer. CHEST Journal. 132(3). 340S–354S. 68 indexed citations
11.
Kumar, Nagi B., Jeffrey P. Krischer, Kathy Allen, et al.. (2007). Safety of Purified Isoflavones in Men With Clinically Localized Prostate Cancer. Nutrition and Cancer. 59(2). 169–175. 18 indexed citations
12.
Park, Jong Y., Weipeng Zheng, Donghwa Kim, et al.. (2007). Candidate tumor suppressor gene SLC5A8 is frequently down-regulated by promoter hypermethylation in prostate tumor. Cancer Detection and Prevention. 31(5). 359–365. 40 indexed citations
13.
Kumar, Nagi B., et al.. (2004). Green Tea Polyphenols and Cancer Chemoprevention: Multiple Mechanisms and Endpoints for Phase II Trials. Nutrition Reviews. 62(5). 204–211. 154 indexed citations
14.
Kumar, Nagi B., Alan Cantor, Kathy Allen, et al.. (2003). The specific role of isoflavones in reducing prostate cancer risk. The Prostate. 59(2). 141–147. 117 indexed citations
15.
Kumar, Nagi B., Alan Cantor, Kathy Allen, Diane Riccardi, & Charles E. Cox. (2002). The specific role of isoflavones on estrogen metabolism in premenopausal women. Cancer. 94(4). 1166–1174. 92 indexed citations
16.
Kumar, Nagi B., Alan Cantor, Kathy Allen, & Charles E. Cox. (2000). Android obesity at diagnosis and breast carcinoma survival. Cancer. 88(12). 2751–2757. 59 indexed citations
17.
Kumar, Nagi B., et al.. (1993). Efficacy of interactive, automated programmed instruction in nutrition education for cancer prevention. Journal of Cancer Education. 8(3). 203–211. 24 indexed citations
18.
Schapira, David V., Nagi B. Kumar, & Gary H. Lyman. (1993). Variation in body fat distribution and breast cancer risk in the families of patients with breast cancer and control families. Cancer. 71(9). 2764–2768. 10 indexed citations
19.
Schapira, David V., Nagi B. Kumar, & Gary H. Lyman. (1991). Obesity, body fat distribution, and sex hormones in breast cancer patients. Cancer. 67(8). 2215–2218. 57 indexed citations
20.
Schapira, David V., Nagi B. Kumar, & Gary H. Lyman. (1990). Serum cholesterol reduction with tamoxifen. Breast Cancer Research and Treatment. 17(1). 3–7. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keitaro Tanaka Breakdown of academic impact, for papers by François Meyer Breakdown of academic impact, for papers by Ömer Küçük Breakdown of academic impact, for papers by Isabelle Bairati Breakdown of academic impact, for papers by Suminori Kono Breakdown of academic impact, for papers by Susan E. McCann Breakdown of academic impact, for papers by Kazue Imai Breakdown of academic impact, for papers by Carlo Sabbà Breakdown of academic impact, for papers by Katherine D. Crew Breakdown of academic impact, for papers by Yoshitaka Tsubono
Rankless by CCL
2026